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Abstract		
Introduction	 Diabetes	 mellitus	 often	 occurs	 in	 schizophrenia	 patients.	 This	 condition	 probably	
related	to	genetic,	antipsychotic	drugs	and	the	development	of	schizophrenia	which	can	 lead	to	
an	unhealthy	lifestyle,	such	as	sedentary	lifestyle	and	increased	of	dietary	intake.	Methods	Cross-
sectional	study	was	held	in	Psychiatry	Department	Cipto	Mangunkusumo	Hospital	in	May	to	June	
2014	to	determine	the	correlation	between	fasting	plasma	glucose	concentration	in	schizophrenia	
patient	to	their	nutritional	status	indicator	and	physical	activity	level.	Results	Forty-seven	subjects	
finished	 the	study	protocol.	The	 result	 showed	that	 the	 fasting	plasma	glucose	concentration	 in	
schizophrenia	 patient	 has	 no	 correlation	 with	 nutritional	 status	 indicator	 and	 physical	 activity	
level,	in	which	91.5%	subject	had	normal	fasting	plasma	glucose.	However,	further	investigation	is	
needed	 because	 31.9%	 subject	were	 overweight,	 48.9%	 subject	were	 obese	 and	 74.5%	 subject	
had	 central	 obesity.	 Conclusion	 No	 correlation	 was	 found	 between	 fasting	 plasma	 glucose	
concentration	 with	 nutritional	 status	 indicators	 and	 physical	 activity	 in	 schizophrenia	 patients.	
However,	most	subjects	had	central	obesity.	
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Introduction 
Eating is human basic daily requirement as energy 
intake is needed to survive. Physical activity has a 
contribution in total energy expenditure. The 
balance between energy intake and energy 
expenditure will maintain a constant body weight 
by a complex system of chemical, hormonal and 
neural mechanisms. Abnormalities of these 
complex systems will result in weight fluctuations 
which may cause impairment in the body system.1 
The body uses energy in form of glucose, 
which can be detected as blood glucose. The term 
hyperglycemia is a condition of high blood glucose 
concentration, which can be due to defects in 
insulin secretion, defects in insulin actions or both,2 
and any impairment in glucose homeostasis.3 
Chronic hyperglycemia may be caused by several 
conditions such as obesity and diabetes mellitus 
(DM). Obesity is also one of the risk factors of 
DM. In person with DM, abnormalities in the 
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metabolism of carbohydrate, protein and fat may 
present.1 Furthermore, DM is associated with long-
term damage, dysfunction, and failure of various 
organs, especially the eyes, kidneys, nerves, heart 
and blood vessels.2 
In relation to obesity and DM, as the main 
concern of this study, although schizophrenia is a 
severe form of the mental illness. Person with 
schizophrenia have a tendency to have lack of 
exercise and poor nutritional status (obesity) in 
which mostly affecting adult population.4 This 
conditions may be the result from the illness itself 
or the medications.5 In schizophrenia patients, the 
imbalance between high energy intake and low 
physical activity will cause obesity.1 Obesity is 
known as one of the risk factor of insulin resistance 
with hyperglycemia as the symptom.6 Studies by 
Sweileh,7 Saddicha,8 Cohen,9 and De Hert,10 
supported that hyperglycemia occured in 
schizophrenia patients. On the other hand, 
Martynikhin11 study showed that fasting glucose 
concentration in schizophrenia patient is generally 
normal. 
There is more concern about these 
conditions because 60% of premature death in 
persons with schizophrenia is due to medical 
conditions, such as cardiovascular, pulmonary and 
infectious diseases. Cardiovascular diseases risk 
factors in schizophrenia, which are preventable, are 
obesity, smoking, DM, hypertension and 
dyslipidemia.5 Thus, the need for screening, 
monitoring and prevention for cardiovascular 
disease in schizophrenia patients since the initial 
diagnostic of schizophrenia is becoming 
important.12 Thus, this study aims to see the 
correlation between fasting plasma glucose 
concentration to nutritional status indicators and 
physical activity level in schizophrenia patients. 
 
Methods 
 
Subjects 
Sixty eight schizophrenia patients, age ranged 
between 19-59 years old, in Adult Clinic Psychiatry 
Cipto Mangunkusumo Hospital were recruited. 
They were diagnosed by the psychiatrist and 
screened accordingly to the study criteria. The 
subjects agreed to participate by signing the 
informed consent and they were assured that all 
information were confidential. Then they followed 
the interview, anthropometric measurements and 
food recall training for filling their 4-day food 
record. All subjects were informed to come again 
one week after their recruitment and after 12 hours 
of overnight fasting for the laboratory fasting 
glucose concentration measurement. Medical 
Ethics Committee of Universitas Indonesia has 
approved the study protocol, and 47 subjects as the 
minimal sample size for a correlation study with an 
assumption of 0.4 as coefficient of correlation 
value, had finished the study protocols. 
 
Measurements 
Data collection was done in May to June 2014. 
Data collected consisted of subject characteristics, 
antipsychotic medications during the study, family 
history of DM, weight, height and waist 
circumferences, physical activities, food histories 
and blood samples for fasting glucose 
concentration. Weight was measured using 
Tanita® digital scale, height was measured using a 
non-stretchable wall-meter and waist circumference 
was measured using the tape measurement. From 
the weight and height measurements, body mass 
index (BMI) was calculated. Physical activity level 
was measured by using International Physical 
Activity short form. Food recall and food record 
were then analyze with Nutrisurvey 2007 food 
processor programme with added indonesian food 
database which were then interpreted as total 
energy, carbohydrate, protein and fat intake. 
Fasting plasma glucose were determined 
enzymatically by using the hexokinase method. 
 
Statistics 
Data were analyzed with Kolmogorov-Smirnov test 
to check the normality distribution of each data. 
Pearson correlation test was used to analyze the 
correlations between variables by using SPSS 
statistical software version 20 for Windows 
operating system. 
Results 
 
The results showed 43 of 47 subjects (91.5%) had 
normal fasting plasma glucose. The subjects were 
mostly less than 40 years old (70.2%), male 
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(57.4%), not married (70%), and not working 
(70.2%). Most subjects had duration of 
schizophrenia for more than 2 years (85.1%). 
Around 85.1% subjects had atypical anti-psychotic 
mediation  for more than 5 years (42.5%). Subject 
who routinely consumed medication was 95.7%. 
Subject who were prescribed polypharmacy 
medications are 57.4%. In terms of nutritional 
status, 80.8% were overweight-obese and mostly 
having abdominal or central obesity (74.5%). 
Almost all the subjects had low-moderate physical 
activity level. However, there was no significant 
difference between the subject’s characteristics, 
dietary intake, nutritional status, and physical 
activities to fasting plasma glucose concentration 
(Table 1). 
Table 2 shows the correlation between 
fasting plasma glucose concentration with 
nutritional status indicators and physical activity 
level in schizophrenia patients. There were no 
correlation between BMI, waist circumference, 
total dietary, carbohydrate, protein and fat intake 
with fasting plasma glucose concentration. 
 
Discussion 
 
To our knowledge, this is the first study in 
Indonesia to investigate the correlation between 
fasting plasma glucose concentration with 
nutritional status indicator and physical activity in 
schizophrenia patients. In this study, only 8.5% 
subjects had abnormal fasting plasma glucose. 
However, regarding to the very high proportions of 
overweight-obesity (80.8%) and central obesity 
(74,5%), this study revealed an unexpected finding, 
i.e. most of the subject’s dietary intake were 
balance with their physical activity and they have a 
normal fasting plasma glucose. 
All subjects with abnormal fasting plasma 
glucose were below 40 years old. This differs from 
De Hert study10 in which the subjects with 
schizophrenia have the highest tendency of glucose 
abnormalities at age over 40 years old. In this 
study, probably only subject with good physical 
ability could visit the psychiatry clinic at Cipto 
Mangunkusumo Hospital. Thus, subjects out of the 
hospital should be included. Fasting plasma 
glucose abnormality in this study affected only 
2.1% versus 6.4% subjects with duration of illness 
less than 2 years and more than 2 years, 
respectively. This finding is similar to De Hert10 
study which showed the lowest glucose 
abnormalities in schizophrenia subject was among 
those patients with duration of illness less than 1.5 
years. The glucose abnormalities were higher in 
subject with longer duration of illness. Thus the 
risk of glucose abnormalities may already happen 
at the beginning of the disease and will increase 
with longer duration of illness. Furthermore, 8.5% 
subject with glucose abnormalities in this study 
received atypical antipsychotic. This result is 
similar to Haider16 study in which 8% subject had 
glucose abnormality. However the mechanism 
between antipsychotic and hyperglycemia was not 
investigated in this study. 
Dietary intake between subjects in this study was 
different because it was highly dependent to their 
family daily food. Most of the subjects have higher 
fat intake which may be one of the risk factor of 
obesity for this study’s subjects. In addition, 48.9% 
subjects had low–moderate physical activity, which 
is different to Yamamoto17 study, i.e. schizophrenia 
subject had a low physical activity. It is widely 
known that low physical activity will need low 
energy requirement, thus will cause obesity if the 
total dietary intake was higher. Furthermore, obese 
subjects with low physical activity may results in 
metabolic overload in the liver and muscle, then 
ends with pancreatic beta cell failures. 
In this study, no correlation was found between 
blood fasting plasma glucose concentration with 
nutritional status indicators and physical activity in 
schizophrenia patients. This may be due to most of 
the subjects had normal fasting plasma glucose 
eventhough they were obese and have low physical 
activity. However, more than 50% subjects in this 
study had central obesity, which is known as one of 
the risk factors for insulin resistance and metabolic 
syndrome. Patients with metabolic syndrome has 
double higher risk for death and triple higher risk to 
have heart attack or stroke compared to those 
without. 
There are some limitations in this study, namely 
subject’s variations, financial problem and family  
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Table 1. Characteristics of subject schizophrenia, the nutritional status and physical activity compare with 
fasting plasma glucose concentration (n=47) 
 
Variable Fasting plasma glucose concentration p 
<100 mg/dl (n=43) 100–125 mg/dl (n=4) 
Age 
19 – <40 years 
40 – 59 years  
 
29 
14 
 
4 
0 
0.397 
Sex 
Male 
Female 
 
29 
14 
 
3 
1 
0.425 
Marriage status 
Married or divorce 
Single 
 
14 
29 
 
2 
2 
0.169 
Education 
Not graduated from Junior high 
Junior high graduated and above 
 
5 
38 
 
0 
4 
0.881 
Work 
Work 
Not working 
 
13 
30 
 
1 
3 
0.753 
Duration of schizophrenia 
<2 years 
>2 years 
 
6 
37 
 
1 
3 
0.822 
DM history in family 
Yes 
No 
 
13 
30 
 
1 
3 
0.417 
Antipsychotic 
Typical 
Atypical 
Combination 
 
5 
36 
2 
 
0 
4 
0 
0.413 
Antipsychotic consumption 
Routine 
Not routine 
 
41 
2 
 
4 
0 
0.864 
Duration antipsychotic medication 
<5 years 
≥5 years 
 
23 
20 
 
4 
0 
0.260 
Medication 
Monopharmacy* 
Polypharmacy** 
 
17 
26 
 
3 
1 
0.526 
BMI (kg/m2) 
<18,5 kg/m2 
18,5 – <23 kg/m2 
23 – 27,5 kg/m2 
>27,5 kg/m2 
 
2 
7 
12 
22 
 
0 
0 
3 
1 
0.494 
Waist circumference 
Male <90 cm 
Male ≥90 cm 
Female <80 cm 
Female ≥80 cm 
 
9 
15 
3 
16 
 
0 
3 
0 
1 
0.130 
Physical activity 
Low <600 MET minute/week 
Moderate 600 – 3000 MET minute/week 
High >3000 MET minute/week 
 
22 
20 
1 
 
1 
3 
0 
0.524 
Note: *one type of medication (typical or atypical); **combination of typical and atypical medication 
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support to finish the protocol. Their awareness on 
the importance of family support in the treatment of 
schizophrenia subject to prevent the cardiovascular 
events was not good enough. 
In conclusion, there was no correlation 
found between blood fasting plasma glucose 
concentration with nutritional status indicators and 
physical activity level in schizophrenia patients in 
this study. However, there was a high proportion of 
central obesity found in this study, which indicated 
schizophrenia may be associated with metabolic 
syndrome. Thus, the present findings can be 
regarded as a small step forward practical 
implication for clinicians. Further investigations are 
suggested to detect other cardiovascular risk factors 
in schizophrenia patients. 
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